The career development activities and research plan outlined in this Research Career Development Award (RCA) are designed to provide the means for the candidate to translate relevant aspects of neurobiology and independently formulate and implement psychopharmacologic treatment trials in pediatric bipolar disorder (BP). Pediatric BP is a devastating illness that can result in permanent disruption of a child's normal development, emotional suffering, aggression and suicide. Pharmacotherapy has been the cornerstone of the management and treatment of pediatric BP. However, there is very little controlled research addressing medication treatment of children and adolescents with BP. In addition, treatment research in child psychiatry has generally not addressed developmental differences in neurobiology or pharmacology, nor attempted to identify biological factors that may be predictors or mediators of treatment response. The proposed study will be the first dose-ranging study of a medication for depression in pediatric BP. It will explore the relationship between platelet 5-HT reuptake blockade and treatment response, as well as examine potential predictors of treatment response. The candidate is certified in child and adolescent psychiatry, and is completing the second year of an NIMH-sponsored post-doctoral research fellowship. Dr. James Perel, Professor of Psychiatry and Pharmacology and Director of the Clinical Pharmacology Program at the University of Pittsburgh's Western Psychiatric Institute and Clinic (WPIC) will serve as Sponsor. The coursework and directed readings in advanced topics of psychopharmacology, clinical trial design, developmental neurobiology and pharmacology, emotional regulation and circadian rhythm, will prepare the candidate to perform biologically-informed treatment research in pediatric BP.
| Lunsford-Avery, Jessica R; Judd, Charles M; Axelson, David A et al. (2012) Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder. Psychiatry Res 200:265-71 |
| Miklowitz, David J; Axelson, David A; George, Elizabeth L et al. (2009) Expressed emotion moderates the effects of family-focused treatment for bipolar adolescents. J Am Acad Child Adolesc Psychiatry 48:643-51 |
| Miklowitz, David J; Axelson, David A; Birmaher, Boris et al. (2008) Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry 65:1053-61 |
| Daviss, W Burleson; Birmaher, Boris; Melhem, Nadine A et al. (2006) Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry 47:927-34 |
| Axelson, David A; Perel, James M; Birmaher, Boris et al. (2005) Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. Am J Psychiatry 162:802-4 |
| Axelson, David A; Bertocci, Michele A; Lewin, Daniel S et al. (2003) Measuring mood and complex behavior in natural environments: use of ecological momentary assessment in pediatric affective disorders. J Child Adolesc Psychopharmacol 13:253-66 |
| Axelson, David; Birmaher, Boris J; Brent, David et al. (2003) A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol 13:463-70 |
| Axelson, David A; Perel, James M; Birmaher, Boris et al. (2002) Sertraline pharmacokinetics and dynamics in adolescents. J Am Acad Child Adolesc Psychiatry 41:1037-44 |
